The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Brief Title: Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC Patients
Official Title: Prospective Study of Complete Remissions Observed With Sunitinib in Patients With Metastatic Renal Cell Carcinoma mRCC)
Study ID: NCT01934452
Brief Summary: This prospective study will investigate the characteristics of mRCC patients at time of CR in comparison with mRCC patients non on CR treated with Sunitinib, in order to provide some answers/ refection leads to the following questions : Can we identify blood specificity at time of CR vs non on CR? Shall we distinguish CR with sunitinib alone from combined CR (sunitinib with local treatment), while in clinical report these 2 cohorts present similar time to recurrence (ALBIGES, ASCO 2010)? Can we identify potential predictive serum biomarkers of recurrence? (With the aim of isolating blood biomarker that can help on treatment discontinuation decision?)
Detailed Description: The main objective of the study is to describe the characteristics of mRCC patients on CR with Sunitinib (Cases) and compare them to the characteristics of mRCC patients non on CR (controls) in order to identify factors associated with the occurrence of complete remission. The results obtained on the sample must be representative of the population targeted by the study. The most appropriate method to obtain a representative sample is probability sampling. A sample size of N = 40 (cases) and N = 80 (Controls) will provide a power of 80% in the detection of a frequency difference between cases and controls corresponding to an OR of 0.24 for a parameter frequency 10% in control arm and an OR of 0.30 for a parameter frequency of around 30% in control arm. The significance level was set at bilateral 5%. The data will be analyzed using SAS software (version 9.1 - SAS Institute, North Carolina, United States).
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
CHU de la Timone, Marseille, Cedex 5, France
CHU Strasbourg, Strasbourg, Cedex, France
CHRU HOTEL DIEU - Service Urologie, Angers Cedex, , France
C.H.U Morvan, Brest, , France
Clinique Victor Hugo, Le Mans, , France
Institut Paoli-Calmettes, Marseille Cedex 09, , France
Institut Paoli-Calmettes / Hôpital de jour, Marseille Cedex 9, , France
Hopital Timone Adultes, Marseille Cedex, , France
CRLC Val d'Aurelle, Montpellier cedex 05, , France
Hopital Europeen Georges Pompidou, Paris Cedex 15, , France
Centre Hospitalier Lyon Sud, Pierre Bénite Cedex, , France
Clinique Chirurgicale de l'Orangerie, Chiliotherapie, Strasbourg, , France
Centre Alexis Vautrin, Vandoeuvre les Nancy, , France
Institut Gustave Roussy, Villejuif Cedex, , France
Name: Pfizer CT.gov Call Center
Affiliation: Pfizer
Role: STUDY_DIRECTOR